All Stories

  1. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  2. Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo
  3. Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers
  4. Metabolomics and doping analysis: promises and pitfalls
  5. Detecting – the 2004 Athens Olympic Games
  6. Hyperhydration-Induced Decrease in Urinary Luteinizing Hormone Concentrations of Male Athletes in Doping Control Analysis
  7. Comparison of gas chromatography/quadrupole time-of-flight and quadrupole Orbitrap mass spectrometry in anti-doping analysis: I. Detection of anabolic-androgenic steroids
  8. Gas chromatographic quadrupole time-of-flight full scan high resolution mass spectrometric screening of human urine in antidoping analysis
  9. Analysis of RBC-microparticles in stored whole blood bags - a promising marker to detect blood doping in sports?
  10. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio
  11. Doping control container for urine stabilization: a pilot study
  12. Athlome Project Consortium: a concerted effort to discover genomic and other “omic” markers of athletic performance
  13. The effect of fasting during Ramadan on parameters of the haematological and steroidal modules of the athletes biological passport - a pilot study
  14. Markers of mesterolone abuse in sulfate fraction for doping control in human urine
  15. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS
  16. Gas chromatographic–mass spectrometric quantitation of busulfan in human plasma for therapeutic drug monitoring: A new on-line derivatization procedure for the conversion of busulfan to 1,4-diiodobutane
  17. Advances in the detection of designer steroids in anti-doping
  18. A generic screening methodology for horse doping control by LC–TOF-MS, GC–HRMS and GC–MS
  19. A Synopsis of the Adverse Analytical and Atypical Findings Between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece
  20. Sports doping: Emerging designer and therapeutic β2-agonists
  21. Chemical derivatization to enhance ionization of anabolic steroids in LC-MS for doping-control analysis
  22. Comparison of multiple linear regression, partial least squares and artificial neural networks for prediction of gas chromatographic relative retention times of trimethylsilylated anabolic androgenic steroids
  23. Evolving concepts and techniques for anti-doping
  24. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories
  25. Examination of the kinetic isotopic effect to the acetylation derivatization for the gas chromatographic-combustion-isotope ratio mass spectrometric doping control analysis of endogenous steroids
  26. Two-step derivatization procedures for the ionization enhancement of anabolic steroids in LC–ESI-MS for doping control analysis
  27. External calibration in Gas Chromatography–Combustion–Isotope Ratio Mass Spectrometry measurements of endogenous androgenic anabolic steroids in sports doping control
  28. Stabilization of human urine doping control samples: a current opinion
  29. Screening in veterinary drug analysis and sports doping control based on full-scan, accurate-mass spectrometry
  30. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin
  31. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry
  32. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin
  33. Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories
  34. Estimating measurement uncertainty in quantitative methods not based on chromatography for doping control purposes
  35. Gas chromatographic quantitative structure–retention relationships of trimethylsilylated anabolic androgenic steroids by multiple linear regression and partial least squares
  36. Two-step silylation procedure for the unified analysis of 190 doping control substances in human urine samples by GC–MS
  37. Direct injection horse urine analysis for the quantification and identification of threshold substances for doping control. III. Determination of salicylic acid by liquid chromatography/quadrupole time-of-flight mass spectrometry
  38. Statistical analysis of fragmentation patterns of electron ionization mass spectra of enolized-trimethylsilylated anabolic androgenic steroids
  39. Direct injection horse-urine analysis for the quantification and confirmation of threshold substances for doping control. IV. Determination of 3-methoxytyramine by hydrophilic interaction liquid chromatography/quadrupole time-of-flight mass spectrometry
  40. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry
  41. Stabilization of human urine doping control samples: II. Microbial degradation of steroids
  42. Stabilization of human urine doping control samples
  43. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine
  44. Direct injection liquid chromatography/electrospray ionization mass spectrometric horse urine analysis for the quantification and confirmation of threshold substances for doping control. II. Determination of theobromine
  45. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities
  46. Direct injection LC/ESI-MS horse urine analysis for the quantification and identification of threshold substances for doping control. I. Determination of hydrocortisone
  47. ISO/IEC 17025 Sysmex R-500 Hematology Reticulocyte Analyzer Validation
  48. Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry
  49. Electrophoretic, size-exclusion high-performance liquid chromatography and liquid chromatography–electrospray ionization ion trap mass spectrometric detection of hemoglobin-based oxygen carriers
  50. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids
  51. Organization of the doping control laboratory in the Athens 2004 Olympic Games: A case study
  52. Doping control analysis in human urine by liquid chromatography–electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: Determination of corticosteroids and quantification of ephedrines, salbutamol and morphine
  53. An overview of the doping control analysis during the Olympic Games of 2004 in Athens, Greece
  54. Metabolism of isometheptene in human urine and analysis by gas chromatography–mass spectrometry in doping control
  55. Another designer steroid: discovery, synthesis, and detection of ?madol? in urine
  56. Quantitative structure–retention relationship study of α-, β1-, and β2-agonists using multiple linear regression and partial least-squares procedures
  57. Determination of xylazine and its metabolites by GC–MS in equine urine for doping analysis
  58. Gas Chromatographic ? Mass Spectrometric Cardiotonic Glycosides Detection in Equine Urine Doping Analysis
  59. Elimination profiles of flurbiprofen and its metabolites in equine urine for doping analysis
  60. Determination of ephedrines in urine by gas chromatography–mass spectrometry
  61. Study of excretion of ecdysterone in human urine
  62. Excretion study of the β2-agonist reproterol in human urine
  63. Doping control analysis: the 6th World Championships of Athletics, Athens, Greece
  64. An expert system for the interpretation of pyrolysis mass spectra of condensation polymers
  65. Quantitative structure-retention relationships in doping control
  66. Principal component analysis for resolving coeluting substances in gas chromatography-mass spectrometry doping control analysis
  67. A method for the interpretation of pyrolysis-mass spectra of polyesters
  68. HEPHESTUS: An expert system in PROLOG for the interpretation of the pyrolysis-mass spectra of polyesters, polyethers and polyureas using the certainty factor model
  69. Assessment of the performance of various search systems for mass spectra files of steroids
  70. HEPHESTUS: An expert system in PROLOG for the interpretation of pyrolysis mass spectra of polyesters, polyethers and polyureas
  71. A method for the interpretation of pyrolysis-mass spectra of polyamides
  72. The interpretation of pyrolysis mass spectra of polymers using a “hybrid” software system based on library searching with heuristics